SLE Patients Face Persistent Risk of Metabolic Syndrome

"The metabolic syndrome (MetS) is a clustering of related CHD (coronary heart disease) risk factors associated with an increased cardiovascular risk in the general population and is a useful clinical tool to identify patients who may warrant more focused CHD risk assessment," the authors wrote. "Understanding the interplay between disease activity, therapeutic exposure and MetS in SLE would better inform CHD risk stratification and help guide treatment regimens in higher risk patients." Renal lupus, active inammatory disease drive metabolic syndrome development. http://www.medpagetoday.com/Rheumatology/Lupus/52668?xid=nl_mpt_DHE_2015-07-21&eun=g721819d0r